Synapse - Find an Expert

693 Results

Bladder cancer patient and provider perspectives on smoking cessation

Journal Article

Mossanen, M.; Smith, A. B.; Onochie, N.; Matulewicz, R.; Bjurlin, M. A.; Kibel, A. S.; Abbas, M.; Shore, N.; Chisolm, S.; Bangs, R.; more...
Urologic Oncology: Seminars and Original Investigations (2023)

Fulltext@MSK | Save

Peripheral arterial disease is associated with higher rates of hospital encounters and mortality in cancer patients: A retrospective study conducted at a tertiary cancer center

Journal Article

Bryce, Y.; Hsu, M.; White, C.; Gonzalez-Aguirre, A.; Friedman, A.; Latzman, J.; Moskowitz, C. S.
Current Problems in Cancer (2023)

Fulltext@MSK | Save

Longitudinal analysis of bladder cancer-specific mortality trends in the United States

Journal Article

Pompa, I. R.; Qi, D.; Ghosh, A.; Goldberg, S. I.; Chino, F.; Efstathiou, J. A.; Kamran, S. C.
Bladder Cancer (2023)

Fulltext@MSK | Save

Phase 3 SELENE study: Ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

Journal Article

Nastoupil, L. J.; Hess, G.; Pavlovsky, M. A.; Danielewicz, I.; Freeman, J.; García-Sancho, A. M.; Glazunova, V.; Grigg, A.; Hou, J. Z.; Janssens, A.; more...
Blood Advances (2023)

Fulltext@MSK | Save

Genomic biomarker discovery in disease progression and therapy response in bladder cancer utilizing machine learning

Journal Article

Liosis, K. C.; Marouf, A. A.; Rokne, J. G.; Ghosh, S.; Bismar, T. A.; Alhajj, R.
Cancers (2023)

Fulltext@MSK | Save

Toward the deimplementation of computed tomography urogram for patients with low- to intermediate-risk microscopic hematuria: A mixed-method study of factors influencing continued use

Journal Article

Birken, S. A.; Matulewicz, R.; Pathak, R.; Wagi, C. R.; Peluso, A. G.; Bundy, R.; Witek, L.; Krol, B.; Parchman, M. L.; Nielsen, M.; more...
Urology Practice (2023)

Fulltext@MSK | Save

Bladder cancer carcinogens: Opportunities for risk reduction

Review

Gaffney, C. D.; Katims, A.; D'Souza, N.; Bjurlin, M. A.; Matulewicz, R. S.
European Urology Focus (2023)

Fulltext@MSK | Save

Background and update for ECOG-ACRIN EA8212: A randomized phase 3 trial of intravesical bacillus Calmette-Guérin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naïve high-grade non–muscle-invasive bladder cancer (BRIDGE)